CHRISTINA COLLIER: Open Payments
NPI 1417671223 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,317 in 68 payments from 19 companies in 2025. Trend: 2023 $369 · 2024 $1,308 · 2025 $1,317
Food & beverage: $1,317
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $159 |
| Medtronic, Inc. | 6 | $151 |
| Insulet Corporation | 9 | $148 |
| Lilly USA, LLC | 9 | $121 |
| BETA BIONICS, INC. | 5 | $108 |
| Novo Nordisk Inc | 4 | $85 |
| Radius Health, Inc. | 3 | $79 |
| Amgen Inc. | 5 | $77 |
| Tandem Diabetes Care, Inc. | 3 | $69 |
| Abbott Laboratories | 3 | $67 |
Products named: JARDIANCE, Omnipod, MOUNJARO, iLet Bionic Pancreas, MINIMED 780G, Tymlos, REPATHA, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across MO — which companies pay providers there.
